Skip to main content
. Author manuscript; available in PMC: 2012 Aug 27.
Published in final edited form as: Diabetes Care. 2005 Mar;28(3):638–644. doi: 10.2337/diacare.28.3.638

Figure 2.

Figure 2

Insulin levels during the hyperglycemic clamp (A), mean of fasting, first-phase, and second-phase insulin levels (B), and mean of fasting, first-phase, and second-phase C-peptide levels (C) during the hyperglycemic (12.5 mmol/l) clamp in type 2 diabetes (T2DM) patients versus obese control (OBC) subjects.